These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 16162523

  • 1. Short communication: Efficacy of parenteral ceftiofur for treatment of systemically mild clinical mastitis in dairy cattle.
    Wenz JR, Garry FB, Lombard JE, Elia R, Prentice D, Dinsmore RP.
    J Dairy Sci; 2005 Oct; 88(10):3496-9. PubMed ID: 16162523
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle.
    Erskine RJ, Bartlett PC, VanLente JL, Phipps CR.
    J Dairy Sci; 2002 Oct; 85(10):2571-5. PubMed ID: 12416809
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of extended ceftiofur intramammary therapy for treatment of subclinical mastitis in lactating dairy cows.
    Oliver SP, Gillespie BE, Headrick SJ, Moorehead H, Lunn P, Dowlen HH, Johnson DL, Lamar KC, Chester ST, Moseley WM.
    J Dairy Sci; 2004 Aug; 87(8):2393-400. PubMed ID: 15328260
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The selective treatment of clinical mastitis based on on-farm culture results: I. Effects on antibiotic use, milk withholding time, and short-term clinical and bacteriological outcomes.
    Lago A, Godden SM, Bey R, Ruegg PL, Leslie K.
    J Dairy Sci; 2011 Sep; 94(9):4441-56. PubMed ID: 21854917
    [Abstract] [Full Text] [Related]

  • 6. Extended ceftiofur therapy for treatment of experimentally-induced Streptococcus uberis mastitis in lactating dairy cattle.
    Oliver SP, Almeida RA, Gillespie BE, Headrick SJ, Dowlen HH, Johnson DL, Lamar KC, Chester ST, Moseley WM.
    J Dairy Sci; 2004 Oct; 87(10):3322-9. PubMed ID: 15377611
    [Abstract] [Full Text] [Related]

  • 7. Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows.
    Deluyker HA, Van Oye SN, Boucher JF.
    J Dairy Sci; 2005 Feb; 88(2):604-14. PubMed ID: 15653527
    [Abstract] [Full Text] [Related]

  • 8. The selective treatment of clinical mastitis based on on-farm culture results: II. Effects on lactation performance, including clinical mastitis recurrence, somatic cell count, milk production, and cow survival.
    Lago A, Godden SM, Bey R, Ruegg PL, Leslie K.
    J Dairy Sci; 2011 Sep; 94(9):4457-67. PubMed ID: 21854918
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intramuscular administration of ceftiofur sodium versus intramammary infusion of penicillin/novobiocin for treatment of Streptococcus agalactiae mastitis in dairy cows.
    Erskine RJ, Bartlett PC, Johnson GL, Halbert LW.
    J Am Vet Med Assoc; 1996 Jan 15; 208(2):258-60. PubMed ID: 8567385
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of intramammary infusion of ceftiofur hydrochloride at drying off for treatment and prevention of bovine mastitis during the nonlactating period.
    Hallberg JW, Wachowski M, Moseley WM, Dame KJ, Meyer J, Wood SL.
    Vet Ther; 2006 Jan 15; 7(1):35-42. PubMed ID: 16598682
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp and Staphylococcus aureus intramammary infections in lactating dairy cows.
    Gillespie BE, Moorehead H, Lunn P, Dowlen HH, Johnson DL, Lamar KC, Lewis MJ, Ivey SJ, Hallberg JW, Chester ST, Oliver SP.
    Vet Ther; 2002 Jan 15; 3(4):373-80. PubMed ID: 12584673
    [Abstract] [Full Text] [Related]

  • 13. Randomized clinical trial to evaluate the efficacy of a 5-day ceftiofur hydrochloride intramammary treatment on nonsevere gram-negative clinical mastitis.
    Schukken YH, Bennett GJ, Zurakowski MJ, Sharkey HL, Rauch BJ, Thomas MJ, Ceglowski B, Saltman RL, Belomestnykh N, Zadoks RN.
    J Dairy Sci; 2011 Dec 15; 94(12):6203-15. PubMed ID: 22118109
    [Abstract] [Full Text] [Related]

  • 14. Negatively controlled, randomized clinical trial to evaluate use of intramammary ceftiofur for treatment of nonsevere culture-negative clinical mastitis.
    Fuenzalida MJ, Ruegg PL.
    J Dairy Sci; 2019 Apr 15; 102(4):3321-3338. PubMed ID: 30738678
    [Abstract] [Full Text] [Related]

  • 15. Financial analysis of alternative treatments for clinical mastitis associated with environmental pathogens.
    Van Eenennaam AL, Gardner IA, Holmes J, Perani L, Anderson RJ, Cullor JS, Guterbock WM.
    J Dairy Sci; 1995 Sep 15; 78(9):2086-95. PubMed ID: 8550918
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relationship between results of in vitro susceptibility tests and outcomes following treatment with pirlimycin hydrochloride in cows with subclinical mastitis associated with gram-positive pathogens.
    Apparao D, Oliveira L, Ruegg PL.
    J Am Vet Med Assoc; 2009 Jun 01; 234(11):1437-46. PubMed ID: 19480625
    [Abstract] [Full Text] [Related]

  • 19. Effects of prepartum intramammary antibiotic therapy on udder health, milk production, and reproductive performance in dairy heifers.
    Borm AA, Fox LK, Leslie KE, Hogan JS, Andrew SM, Moyes KM, Oliver SP, Schukken YH, Hancock DD, Gaskins CT, Owens WE, Norman C.
    J Dairy Sci; 2006 Jun 01; 89(6):2090-8. PubMed ID: 16702275
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation.
    Owens WE, Nickerson SC, Ray CH.
    J Dairy Sci; 1999 Mar 01; 82(3):645-7. PubMed ID: 10194686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.